Dr. Nirali Vora, MD

Dr. Vora practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Vora's NPI, 1578797460, was assigned on May 7, 2009. Dr. Vora graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2009. Dr. Vora holds California license A114115.

Dr. Vora's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Vora's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Vora is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Vora to 1 more hospital, named with a free account. Dr. Vora's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vora practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Vora's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Vora is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Vora is licensed in California.

Dmand AI lists cerebrovascular disease, mobility impairment, nerve damage, stroke and vertigo among the conditions Dr. Vora treats.

CMS data shows 372 Medicare services from Dr. Vora across 7 procedure codes in 2024, for 213 Medicare patients. Medicare paid $44,480 for them.

CMS counts 213 Medicare patients who saw Dr. Vora in 2024. The largest group is 75 to 84, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vora's median patient age at 66, with 56% women.

In 2024, Dr. Vora wrote 62 Medicare Part D claims for 26 patients. 95% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $723 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Vora for performance year 2024, reported as part of a group. Dr. Vora accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vora as offering telehealth.

Dmand AI links 13 papers to Dr. Vora, published from 2010 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Stroke, Brain and Curriculum. Dr. Vora has published most often in Circulation. Dr. Vora's most frequent co-authors are Deanna Rae Saylor, MD, MHS, Gregory W. Albers, MD and Aaron Lee Berkowitz, MD, PhD.

Dmand AI links Dr. Vora to 1 clinical trial. Conditions studied include Ischemic Stroke and Stroke.

CMS Open Payments shows 20 general payments to Dr. Vora from 4 drug and device companies from 2017 to 2025. Honoraria make up the largest share, 46% of the total. Portola Pharmaceuticals, LLC paid the most, $3,258.

Dr. Vora graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2009.

Dr. Vora is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.